2001
DOI: 10.1021/cr000700m
|View full text |Cite
|
Sign up to set email alerts
|

PeroralRoute:  An Opportunity for Protein and Peptide Drug Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
61
0

Year Published

2004
2004
2023
2023

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 191 publications
(63 citation statements)
references
References 309 publications
0
61
0
Order By: Relevance
“…Many researchers have attempted to administer insulin orally since its discovery in 1922 [169]. However, the oral bioavailability of insulin is severely hampered by its inherent instability in the gastrointestinal (GI) tract and its low permeability across biological membranes in the intestine [170,171]. The concept of closed loop control of glucose, in which continuous glucose sensing is coupled to a fully automated insulin delivery device, without human input, has been an attractive idea for diabetes management [170][171][172].…”
Section: Responsive Polymer-inorganic Hybrid Nanogels In Drug Deliverymentioning
confidence: 99%
See 1 more Smart Citation
“…Many researchers have attempted to administer insulin orally since its discovery in 1922 [169]. However, the oral bioavailability of insulin is severely hampered by its inherent instability in the gastrointestinal (GI) tract and its low permeability across biological membranes in the intestine [170,171]. The concept of closed loop control of glucose, in which continuous glucose sensing is coupled to a fully automated insulin delivery device, without human input, has been an attractive idea for diabetes management [170][171][172].…”
Section: Responsive Polymer-inorganic Hybrid Nanogels In Drug Deliverymentioning
confidence: 99%
“…However, the oral bioavailability of insulin is severely hampered by its inherent instability in the gastrointestinal (GI) tract and its low permeability across biological membranes in the intestine [170,171]. The concept of closed loop control of glucose, in which continuous glucose sensing is coupled to a fully automated insulin delivery device, without human input, has been an attractive idea for diabetes management [170][171][172]. Considering the attractive multifunctional capabilities of responsive polymer-inorganic hybrid nanogels, we think that it is possible to design a single hybrid nanogel that may simultaneously act as a monitoring system (glucose sensor) to evaluate an input (glucose levels) and a triggerable delivery system to predictably control the output (insulin infusion rate).…”
Section: Responsive Polymer-inorganic Hybrid Nanogels In Drug Deliverymentioning
confidence: 99%
“…Such drug formulations rely on their ability to protect P/P drugs from degradative gastrointestinal enzymatic attack by delivering the drug to the most favorable site for absorption (e.g., the large intestine). In developing such DDS, the concepts of enzyme inhibitors, absorption enhancers, and/or bioadhesive polymers can also be considered in order to increase the efficiency of P/P delivery to absorptive mucosa that, in turn, increases the drug absorption into the systemic circulation [21].…”
Section: Drug Delivery Devicesmentioning
confidence: 99%
“…42 Additionally, the delivery of both proteins and peptides can be problematic unless specially facilitated, 43 especially when treated as oral drugs. 44 To summarize, people have started to look for other alternatives with high comparability and better performance compared with the skeletons coming from native proteins to overcome these challenges.…”
mentioning
confidence: 99%